These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33411730)

  • 21. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
    Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
    Nakayama R; Ueno Y; Ueda K; Honda T
    Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
    Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
    Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
    Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
    Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
    Ishikawa C; Mori N
    Oncol Rep; 2017 Nov; 38(5):3197-3204. PubMed ID: 29048633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.
    Kadota A; Moriguchi M; Watanabe T; Sekine Y; Nakamura S; Yasuno T; Ohe T; Mashino T; Fujimuro M
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
    Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
    Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein.
    Ishido S; Choi JK; Lee BS; Wang C; DeMaria M; Johnson RP; Cohen GB; Jung JU
    Immunity; 2000 Sep; 13(3):365-74. PubMed ID: 11021534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.
    Tomescu C; Law WK; Kedes DH
    J Virol; 2003 Sep; 77(17):9669-84. PubMed ID: 12915579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
    Bi X; Yang L; Mancl ME; Barnes BJ
    J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
    Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
    PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
    Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
    Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
    Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
    Shrestha P; Davis DA; Veeranna RP; Carey RF; Viollet C; Yarchoan R
    PLoS Pathog; 2017 Sep; 13(9):e1006628. PubMed ID: 28922425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
    Haddad L; El Hajj H; Abou-Merhi R; Kfoury Y; Mahieux R; El-Sabban M; Bazarbachi A
    Leukemia; 2008 Apr; 22(4):826-34. PubMed ID: 18094712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.